Literature DB >> 15670907

Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.

Shugeng Cao1, Caleb Foster, Marni Brisson, John S Lazo, David G I Kingston.   

Abstract

Separation of an extract of a Xestospongia sp., guided by bioassay against Cdc25B, led to the isolation of nine compounds, halenaquinone (1), xestoquinone (2), adociaquinones A (3) and B (4), 3-ketoadociaquinones A (5) and B (6), tetrahydrohalenaquinones A (7) and B (8), and 13-O-methyl xestoquinol sulfate (9). The structures of the new natural products 6 and 9 were established on the basis of extensive one- and two-dimensional NMR studies. Compounds 1, 4, and 6 inhibited recombinant human Cdc25B in vitro with IC50 values of 0.7, 0.07, and 0.2 microM, respectively, and were 19- to 150-fold less active against two related protein phosphatases. Compound 4 blocked cell cycle progression through mitosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670907     DOI: 10.1016/j.bmc.2004.11.039

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

1.  Xestosaprols from the Indonesian marine sponge Xestospongia sp.

Authors:  Jingqiu Dai; Analia Sorribas; Wesley Y Yoshida; Michelle Kelly; Philip G Williams
Journal:  J Nat Prod       Date:  2010-06-25       Impact factor: 4.050

2.  Structures and mechanisms of antitumor agents: xestoquinones uncouple cellular respiration and disrupt HIF signaling in human breast tumor cells.

Authors:  Lin Du; Fakhri Mahdi; Sandipan Datta; Mika B Jekabsons; Yu-Dong Zhou; Dale G Nagle
Journal:  J Nat Prod       Date:  2012-08-31       Impact factor: 4.050

Review 3.  Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?

Authors:  Brian Budke; Wei Lv; Alan P Kozikowski; Philip P Connell
Journal:  ChemMedChem       Date:  2016-10-26       Impact factor: 3.466

Review 4.  A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors.

Authors:  Ahmed Bakr Abdelwahab; Eslam Reda El-Sawy; Atef G Hanna; Denyse Bagrel; Gilbert Kirsch
Journal:  Molecules       Date:  2022-04-07       Impact factor: 4.927

5.  Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.

Authors:  Paul A Johnston; Caleb A Foster; Marni Brisson Tierno; Tong Ying Shun; Sunita N Shinde; William D Paquette; Kay M Brummond; Peter Wipf; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2009-06       Impact factor: 1.738

6.  Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.

Authors:  Shugeng Cao; Brian T Murphy; Caleb Foster; John S Lazo; David G I Kingston
Journal:  Bioorg Med Chem       Date:  2008-11-08       Impact factor: 3.641

Review 7.  Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2009-03-19

Review 8.  Kinase inhibitors from marine sponges.

Authors:  Danielle Skropeta; Natalie Pastro; Ana Zivanovic
Journal:  Mar Drugs       Date:  2011-10-24       Impact factor: 6.085

9.  Dual-Specificity Phosphatase CDC25A/B Inhibitor Identified from a Focused Library with Nonelectrophilic Core Structure.

Authors:  Ayako Tsuchiya; Go Hirai; Yusuke Koyama; Kana Oonuma; Yuko Otani; Hiroyuki Osada; Mikiko Sodeoka
Journal:  ACS Med Chem Lett       Date:  2012-02-15       Impact factor: 4.345

10.  Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities.

Authors:  Shou-Ping Shih; Man-Gang Lee; Mohamed El-Shazly; Yung-Shun Juan; Zhi-Hong Wen; Ying-Chi Du; Jui-Hsin Su; Ping-Jyun Sung; Yu-Cheng Chen; Juan-Cheng Yang; Yang-Chang Wu; Mei-Chin Lu
Journal:  Mar Drugs       Date:  2015-05-20       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.